• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

产后心脏逆重构的程度反映在尿蛋白质组中。

The extent of postpartum cardiac reverse remodeling is reflected in urine proteome.

机构信息

Cardiovascular R&D Centre - UnIC@RISE, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Alameda Prof. Hernâni Monteiro, 4200-319, Porto, Portugal.

Faculdade de Medicina Dentária, Universidade do Porto, 4200-393, Porto, Portugal.

出版信息

Sci Rep. 2024 Jun 27;14(1):14815. doi: 10.1038/s41598-024-65612-1.

DOI:10.1038/s41598-024-65612-1
PMID:38937573
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11211500/
Abstract

The association of postpartum cardiac reverse remodeling (RR) with urinary proteome, particularly in pregnant women with cardiovascular (CV) risk factors who show long-term increased risk of cardiovascular disease and mortality is unknown. We aim to profile the urinary proteome in pregnant women with/without CV risk factors to identify proteins associated with postpartum RR. Our study included a prospective cohort of 32 healthy and 27 obese and/or hypertensive and/or diabetic pregnant women who underwent transthoracic echocardiography, pulse-wave-velocity, and urine collection at the 3rd trimester and 6 months postpartum. Shotgun HPLC-MS/MS profiled proteins. Generalized linear mixed-effects models were used to identify associations between urinary proteins and left ventricle mass (LVM), a surrogate of RR. An increase in arterial stiffness was documented from 3rd trimester to 6 months after delivery, being significantly elevated in women with CV risk factors. In addition, the presence of at least one CV risk factor was associated with worse LVM RR. We identified 6 and 11 proteins associated with high and low LVM regression, respectively. These proteins were functionally linked with insulin-like growth factor (IGF) transport and uptake regulation by IGF binding-proteins, platelet activation, signaling and aggregation and the immune system's activity. The concentration of IGF-1 in urine samples was associated with low LVM regression after delivery. Urinary proteome showed a predicting potential for identifying pregnant women with incomplete postpartum RR.

摘要

产后心脏逆向重构(RR)与尿蛋白质组的关联,特别是在有心血管(CV)危险因素的孕妇中,这些孕妇长期存在心血管疾病和死亡率增加的风险,目前尚不清楚。我们旨在对有/无 CV 危险因素的孕妇进行尿蛋白质组分析,以确定与产后 RR 相关的蛋白质。我们的研究纳入了 32 名健康孕妇和 27 名肥胖和/或高血压和/或糖尿病孕妇,这些孕妇在孕晚期和产后 6 个月时接受了经胸超声心动图、脉搏波速度和尿液采集。使用高效液相色谱-串联质谱法(HPLC-MS/MS)进行蛋白质谱分析。使用广义线性混合效应模型来确定尿液蛋白与左心室质量(LVM)之间的关联,LVM 是 RR 的替代指标。从孕晚期到产后 6 个月,动脉僵硬度增加,有 CV 危险因素的女性显著升高。此外,至少有一种 CV 危险因素的存在与更差的 LVM RR 相关。我们鉴定出 6 种和 11 种与高和低 LVM 回归分别相关的蛋白质。这些蛋白质与胰岛素样生长因子(IGF)的运输和摄取调节、血小板激活、信号转导和聚集以及免疫系统的活性有关。尿液样本中 IGF-1 的浓度与产后 LVM 回归较低有关。尿蛋白质组显示出预测未完全恢复产后 RR 的孕妇的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e0/11211500/c5c931934118/41598_2024_65612_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e0/11211500/c5c931934118/41598_2024_65612_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e0/11211500/c5c931934118/41598_2024_65612_Fig1_HTML.jpg

相似文献

1
The extent of postpartum cardiac reverse remodeling is reflected in urine proteome.产后心脏逆重构的程度反映在尿蛋白质组中。
Sci Rep. 2024 Jun 27;14(1):14815. doi: 10.1038/s41598-024-65612-1.
2
Cardiovascular risk factors during pregnancy impact the postpartum cardiac and vascular reverse remodeling.怀孕期间的心血管危险因素会影响产后心脏和血管的逆向重构。
Am J Physiol Heart Circ Physiol. 2023 Oct 1;325(4):H774-H789. doi: 10.1152/ajpheart.00200.2023. Epub 2023 Jul 21.
3
The PERInatal MYocardial Remodeling (PERIMYR) cohort study protocol: A prospective study of cardiac remodeling and "recovery" in pregnancy as a model to understand the impact of comorbidities in cardiac remodeling and reverse remodeling.PERInatal MYocardial Remodeling (PERIMYR) 队列研究方案:一项关于妊娠中心脏重构和“恢复”的前瞻性研究,旨在了解合并症对心脏重构和逆重构的影响。
Rev Port Cardiol. 2023 Jun;42(6):585-596. doi: 10.1016/j.repc.2022.08.015. Epub 2023 Mar 21.
4
Routine first-trimester pre-eclampsia screening and maternal left ventricular geometry.常规早孕期子痫前期筛查与母体左心室几何形态。
Ultrasound Obstet Gynecol. 2024 Jan;63(1):75-80. doi: 10.1002/uog.26306.
5
Cardiac magnetic resonance imaging to assess the impact of maternal habitus on cardiac remodeling during pregnancy.心脏磁共振成像评估母体体型对妊娠期间心脏重构的影响。
Am J Obstet Gynecol. 2016 May;214(5):640.e1-6. doi: 10.1016/j.ajog.2015.11.014. Epub 2015 Nov 22.
6
Maternal hemodynamic profile during pregnancy and in the post-partum in hypertensive disorders of pregnancy and fetal growth restriction.妊娠期高血压疾病和胎儿生长受限患者孕期及产后的母体血流动力学特征。
Am J Obstet Gynecol MFM. 2023 Mar;5(3):100841. doi: 10.1016/j.ajogmf.2022.100841. Epub 2022 Dec 21.
7
Postpartum cardiovascular function in patients with hypertensive disorders of pregnancy: a longitudinal study.妊娠高血压疾病患者产后心血管功能:一项纵向研究。
Am J Obstet Gynecol. 2023 Sep;229(3):292.e1-292.e15. doi: 10.1016/j.ajog.2023.03.019. Epub 2023 Mar 17.
8
The impact of echocardiographic indexation to evaluate cardiac reverse remodeling throughout pregnancy and postpartum.超声心动图指数评估对妊娠期及产后心脏逆重构的影响。
Rev Port Cardiol. 2024 Mar;43(3):107-127. doi: 10.1016/j.repc.2023.04.014. Epub 2023 Jul 24.
9
Ultrasound study of carotid and cardiac remodeling and cardiac-arterial coupling in normal pregnancy and preeclampsia: a case control study.正常妊娠和子痫前期中颈动脉和心脏重塑以及心脏-动脉耦合的超声研究:一项病例对照研究
BMC Pregnancy Childbirth. 2014 Mar 25;14:113. doi: 10.1186/1471-2393-14-113.
10
Myocardial tissue characterization and strain analysis in healthy pregnant women using cardiovascular magnetic resonance native T1 mapping and feature tracking technique.应用心血管磁共振 native T1 mapping 和特征追踪技术对健康孕妇的心肌组织特征和应变进行分析。
J Cardiovasc Magn Reson. 2018 Aug 2;20(1):52. doi: 10.1186/s12968-018-0476-5.

本文引用的文献

1
The Cardiometabolic Impact of Rebaudioside A Exposure during the Reproductive Stage.生育期接触莱鲍迪苷A对心脏代谢的影响。
Biology (Basel). 2024 Mar 2;13(3):163. doi: 10.3390/biology13030163.
2
2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee.2023年美国心脏病学会射血分数保留的心力衰竭管理专家共识决策路径:美国心脏病学会解决方案集监督委员会报告
J Am Coll Cardiol. 2023 May 9;81(18):1835-1878. doi: 10.1016/j.jacc.2023.03.393. Epub 2023 Apr 19.
3
Innate and Adaptive Immune Systems in Physiological and Pathological Pregnancy.
生理和病理妊娠中的先天性和适应性免疫系统
Biology (Basel). 2023 Mar 3;12(3):402. doi: 10.3390/biology12030402.
4
The PERInatal MYocardial Remodeling (PERIMYR) cohort study protocol: A prospective study of cardiac remodeling and "recovery" in pregnancy as a model to understand the impact of comorbidities in cardiac remodeling and reverse remodeling.PERInatal MYocardial Remodeling (PERIMYR) 队列研究方案:一项关于妊娠中心脏重构和“恢复”的前瞻性研究,旨在了解合并症对心脏重构和逆重构的影响。
Rev Port Cardiol. 2023 Jun;42(6):585-596. doi: 10.1016/j.repc.2022.08.015. Epub 2023 Mar 21.
5
Platelets and endothelial dysfunction in gestational diabetes mellitus.妊娠期糖尿病中的血小板与血管内皮功能障碍。
Acta Physiol (Oxf). 2023 Apr;237(4):e13940. doi: 10.1111/apha.13940. Epub 2023 Feb 6.
6
Biomarkers in Heart Failure: From Research to Clinical Practice.心力衰竭的生物标志物:从研究到临床实践。
Ann Lab Med. 2023 May 1;43(3):225-236. doi: 10.3343/alm.2023.43.3.225. Epub 2022 Dec 22.
7
Maternal plasma proteome profiling of biomarkers and pathogenic mechanisms of early-onset and late-onset preeclampsia.母体外周血蛋白质组生物标志物谱分析与早发型和晚发型子痫前期发病机制的研究。
Sci Rep. 2022 Nov 9;12(1):19099. doi: 10.1038/s41598-022-20658-x.
8
Serum peptidomic screening identified circulating peptide biomarkers predictive for preeclampsia.血清肽组学筛查确定了可预测先兆子痫的循环肽生物标志物。
Front Cardiovasc Med. 2022 Oct 11;9:946433. doi: 10.3389/fcvm.2022.946433. eCollection 2022.
9
Platelet aggregation in normal pregnancy.正常妊娠中的血小板聚集。
Clin Chim Acta. 2022 Nov 1;536:94-97. doi: 10.1016/j.cca.2022.09.016. Epub 2022 Sep 19.
10
Biomarkers of Myocardial Injury and Remodeling in Heart Failure.心力衰竭中心肌损伤与重塑的生物标志物
J Pers Med. 2022 May 16;12(5):799. doi: 10.3390/jpm12050799.